Efficacy and Safety of Donepezil 23 mg/Day in Patients with Moderate-to-Severe Alzheimer's Disease with Concomitant Memantine Use

被引：0
|
作者：
Doody, Rachelle S.
Ramos, Harry
Faison, Warachal
Zou, Heng
机构：
来源：
NEUROLOGY | 2011年 / 76卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A619 / A620
页数：2
相关论文
共 50 条
  • [1] Efficacy and Safety of Donepezil 23 mg versus Donepezil 10 mg for Moderate-to-Severe Alzheimer's Disease: A Subgroup Analysis in Patients Already Taking or Not Taking Concomitant Memantine
    Doody, Rachelle S.
    Geldmacher, David S.
    Farlow, Martin R.
    Sun, Yijun
    Moline, Margaret
    Mackell, Joan
    [J]. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2012, 33 (2-3) : 164 - 173
  • [2] Efficacy and Safety of Donepezil 23 mg/d vs. Donepezil 10 mg/d in Patients with Moderate to Severe Alzheimer's Disease: Impact of Concomitant Memantine Use.
    Doody, R. S.
    Ramos, H.
    Faison, W.
    Zou, H.
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2011, 59 : S30 - S30
  • [3] Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease
    Howard, Robert
    McShane, Rupert
    Lindesay, James
    Ritchie, Craig
    Baldwin, Ashley
    Barber, Robert
    Burns, Alistair
    Dening, Tom
    Findlay, David
    Holmes, Clive
    Hughes, Alan
    Jacoby, Robin
    Jones, Rob
    Jones, Roy
    McKeith, Ian
    Macharouthu, Ajay
    O'Brien, John
    Passmore, Peter
    Sheehan, Bart
    Juszczak, Edmund
    Katona, Cornelius
    Hills, Robert
    Knapp, Martin
    Ballard, Clive
    Brown, Richard
    Banerjee, Sube
    Onions, Caroline
    Griffin, Mary
    Adams, Jessica
    Gray, Richard
    Johnson, Tony
    Bentham, Peter
    Phillips, Patrick
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (10): : 893 - 903
  • [4] Donepezil 23 mg in Asian patients with moderate-to-severe Alzheimer's disease
    Han, S. -H.
    Lee, J. -H.
    Kim, S. Y.
    Park, K. W.
    Chen, C.
    Tripathi, M.
    Dash, A.
    Kubota, N.
    [J]. ACTA NEUROLOGICA SCANDINAVICA, 2017, 135 (02): : 252 - 256
  • [5] Efficacy and Safety of Donepezil 23 mg/Day vs. Donepezil 10 mg/Day in Moderate-to-Severe Alzheimer's Disease: Subgroup Analysis of US Participants in a Global Study
    Salloway, Stephen
    Ramos, Harry
    Faison, Warachal
    Zou, Heng
    [J]. NEUROLOGY, 2011, 76 (09) : A622 - A622
  • [6] Higher-Dose (23 mg/day) Donepezil Formulation for the Treatment of Patients with Moderate-to-Severe Alzheimer's Disease
    Christensen, Daniel D.
    [J]. POSTGRADUATE MEDICINE, 2012, 124 (06) : 110 - 116
  • [7] Safety and tolerability of donepezil 23 mg in moderate to severe Alzheimer's disease
    Martin Farlow
    Felix Veloso
    Margaret Moline
    Jane Yardley
    Elimor Brand-Schieber
    Francesco Bibbiani
    Heng Zou
    Timothy Hsu
    Andrew Satlin
    [J]. BMC Neurology, 11
  • [8] Safety and tolerability of donepezil 23 mg in moderate to severe Alzheimer's disease
    Farlow, Martin
    Veloso, Felix
    Moline, Margaret
    Yardley, Jane
    Brand-Schieber, Elimor
    Bibbiani, Francesco
    Zou, Heng
    Hsu, Timothy
    Satlin, Andrew
    [J]. BMC NEUROLOGY, 2011, 11
  • [9] Effects of donepezil in patients with moderate-to-severe Alzheimer's disease discontinuing memantine monotherapy
    Sakka, P.
    Tsolaki, M.
    Hort, J.
    Hager, K.
    Soininen, H.
    Lopez-Pousa, S.
    Li, C.
    Schwam, E.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 : 58 - 58
  • [10] Donepezil 23 mg/Day Improves Cognitive Abilities in Patients with Moderate-to-Severe Alzheimer's Disease: Evaluating the Impact on Language
    Schmitt, Frederick A.
    Ferris, Steven H.
    Mackell, Joan
    Richardson, Sharon
    Sun, Yijun
    [J]. NEUROLOGY, 2011, 76 (09) : A512 - A513
12345